Pharma Excipients

News on Pharma Excipients

Nanosized Drug Delivery Systems to Fight Tuberculosis

Tuberculosis (TB) is currently the second deadliest infectious disease. Existing antitubercular therapies are long, complex, and have severe side effects that result in low patient compliance. In this context, nanosized drug delivery…

CELPHERE – Microcrystalline Cellulose seed core

Are you developing MUPS? Difficulties with crushing pellets? Pellet aggregation? Asahi Kasei is the leading manufacturer and supplier of functional excipients such as microcrystalline cellulose (MCC) in Japan. Read more about the…

Nitrosamine Risk Assessments in Oligonucleotides

The European Medicines Agency, the U.S. Food and Drug Administration, and other regulatory agencies expect that all pharmaceutical products be assessed for the potential presence of N-nitrosoamine (nitrosamine) impurities. This white paper…